PSYCHOLOGICAL THERAPIES IN PARKINSON'S DISEASE

被引：0
|
作者：
Brown, Richard [1 ,2 ]
机构：
[1] Kings Coll London, Inst Psychiat, Neuropsychol & Clin Neurosci, London, England
[2] Kings Coll London, Inst Psychiat, Dept Psychol, London, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2019年 / 90卷
关键词：
D O I：
10.1136/jnnp-2019-BNPA.4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
4
引用
收藏
页码：A2 / A2
页数：1
相关论文
共 50 条
  • [31] Therapies for Restless Legs in Parkinson's Disease
    De Cock, Valerie Cochen
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2019, 21 (11)
  • [32] Possible therapies of Parkinson's disease: A review
    Chakraborty, Ashok
    Brauer, Sam
    Diwan, Anil
    JOURNAL OF CLINICAL NEUROSCIENCE, 2020, 75 : 1 - 4
  • [33] The need for neuroprotective therapies in Parkinson's disease
    Poewe, Werner
    NEUROLOGY, 2006, 66 (10) : S2 - S9
  • [34] Rationale for current therapies in Parkinson's disease
    Romrell, J
    Fernandez, HH
    Okun, MS
    EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (10) : 1747 - 1761
  • [35] Novel targeted therapies for Parkinson’s disease
    Theodora Ntetsika
    Paraskevi-Evita Papathoma
    Ioanna Markaki
    Molecular Medicine, 2021, 27
  • [36] An overview of novel therapies for Parkinson's disease
    Fahn, S
    EXPERIMENTAL NEUROLOGY, 1997, 144 (01) : 21 - 23
  • [37] Emerging therapies for neuromodulation in Parkinson's disease
    Martinez-Nunez, Alfonso Enrique
    Justich, Maria Belen
    Okun, Michael S.
    Fasano, Alfonso
    NEUROTHERAPEUTICS, 2024, 21 (03)
  • [38] Activating therapies for patients with Parkinson's disease
    Ebersbach, G.
    Ceballos-Baumann, A.
    NERVENHEILKUNDE, 2008, 27 (08) : 746 - 756
  • [39] Monoclonal antibody therapies in Parkinson's disease
    Aman, Yahyah
    NATURE AGING, 2022, 2 (09): : 770 - 770
  • [40] Existing dopaminergic therapies for Parkinson's disease
    Dutta, Aloke K.
    Le, Weidong
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (12) : 1613 - 1625
12345